文献速递系统性红斑狼疮血管炎

系统性红斑狼疮中的脑血管事件:一项国际起始队列研究结果

Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-09-01

该国际多民族/种族起始队列纳入1826例系统性红斑狼疮患者,每年评估19种神经精神事件(含5类脑血管事件)。共82例发生109次脑血管事件,以卒中和短暂性脑缺血为主,多数归因于狼疮;医生评估多数缓解或改善,但患者报告健康相关生活质量持续下降。

要点

  • 脑血管事件是系统性红斑狼疮第四常见神经精神事件,109次事件中103次归因于狼疮。
  • 主要事件为卒中(109例中60例)和短暂性脑缺血(109例中28例)。
  • 医生评估多数缓解或改善,但患者报告SF-36汇总及子量表评分持续降低。

核心结论

  • 脑血管事件是系统性红斑狼疮第四常见神经精神事件,通常归因于狼疮。
  • 与医生报告的良好结局相反,患者报告脑血管事件后健康相关生活质量持续下降。

研究设计与样本

  • 国际多民族/种族起始队列研究,纳入1826例系统性红斑狼疮患者,每年评估19种神经精神事件(含5类脑血管事件)。
  • 收集全球疾病活动度(SLE活动指数2000)、损伤评分(SLE国际协作组/美国风湿病学会损伤指数)和SF-36评分。
  • 采用至事件时间分析、线性和逻辑回归及多状态模型。

主要发现

  • 1826例中82例发生109次脑血管事件,其中103次归因于SLE,44次在入组时即被识别。
  • 109次事件中卒中60例、短暂性脑缺血28例。
  • 脑血管事件与其他归因于SLE的神经精神事件、非SLE归因的神经精神事件、非洲 ancestry(美国SLICC站点)及器官损伤评分升高相关。
  • 狼疮抗凝物增加首次卒中、窦血栓形成和短暂性脑缺血发作的风险。
  • 医生评估显示多数患者缓解或改善,但患者报告脑血管事件后SF-36汇总及子量表评分持续降低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the frequency, characteristics, and outcomes of cerebrovascular events (CerVEs), as well as clinical and autoantibody associations in a multiethnic/racial inception cohort of patients with systemic lupus erythematosus (SLE). METHODS: A total of 1,826 patients were assessed annually for 19 neuropsychiatric (NP) events, including 5 types of CerVEs: 1) stroke, 2) transient ischemia, 3) chronic multifocal ischemia, 4) subarachnoid/intracranial hemorrhage, and 5) sinus thrombosis. Global disease activity (Systemic Lupus Erythematosus Disease [SLE] Activity Index 2000), damage scores (SLE International Collaborating Clinics/American College of Rheumatology Damage Index), and Short Form 36 (SF-36) scores were collected. Time to event, linear and logistic regressions, and multistate models were used as appropriate. RESULTS: CerVEs were the fourth most frequent NP event: 82 of 1,826 patients had 109 events; of these events, 103 were attributed to SLE, and 44 were identified at the time of enrollment. The predominant events were stroke (60 of 109 patients) and transient ischemia (28 of 109 patients). CerVEs were associated with other NP events attributed to SLE, non-SLE-attributed NP events, African ancestry (at US SLICC sites), and increased organ damage scores. Lupus anticoagulant increased the risk of first stroke and sinus thrombosis and transient ischemic attack. Physician assessment indicated resolution or improvement in the majority of patients, but patients reported sustained reduction in SF-36 summary and subscale scores following a CerVE. CONCLUSION: CerVEs, the fourth most frequent NP event in SLE, are usually attributable to lupus. In contrast to good physician-reported outcomes, patients reported a sustained reduction in health-related quality of life following a CerVE.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Hanly JG, Li Q, Su L, et al. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Care Res (Hoboken). 2018. PMID: 29316357. doi:10.1002/acr.23509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。